Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
01/1997
01/08/1997EP0751939A1 Naphthylamides as central nervous system agents
01/08/1997EP0751773A1 Tocolytic oxytocin receptor antagonists
01/08/1997EP0751767A1 Therapeutic guanidines
01/08/1997EP0606251B1 Fungicides
01/08/1997EP0558657B1 Retroviral protease inhibitors
01/07/1997US5591860 Retroviral protease inhibiting compounds
01/07/1997US5591754 Benzoylguanidines, pharmaceutical composition containing them and treatment of arrthythmias therewith
01/07/1997US5591744 1,4-dihydro-4-oxoquinoline-3-carboxylate derivatives; microbiocides
01/03/1997WO1997000251A1 Anti-ischaemic hydroxylamine derivatives and pharmaceutical compositions
01/02/1997EP0750609A1 Isoprenyl transferase inhibitors
01/02/1997EP0750607A1 2-(aminoalkoxy)phenylalkylamines with antiinflammatory activity
01/01/1997CN1139431A Heterocyclic compounds for the treatment of CNS and cardiovascular disorders
01/01/1997CN1139427A Malarial aspartic protease inhibitors
01/01/1997CN1139108A Substituted benzothienylpiperazines their use as medicaments, and processes for their preparation
12/1996
12/31/1996US5589500 Substituted 1,1,2-triphenylbutenes and their use in the treatment of cancer
12/31/1996US5589470 Reducing tetracycline resistance in living cells
12/27/1996WO1996041795A1 Benzamide derivatives and their use as vasopressin antagonists
12/27/1996WO1996041630A1 Phenoxy piperazine derivatives for treating disorders of the dopamine system
12/27/1996EP0749313A1 Method for treating 5ht 2b receptor related conditions
12/27/1996EP0749302A1 Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof
12/27/1996CA2223869A1 Benzamide derivatives and their use as vasopressin antagonists
12/27/1996CA2222225A1 Phenoxy piperazine derivatives for treating disorders of the dopamine system
12/25/1996CN1138851A Metalloproteinase inhibitors
12/25/1996CN1138583A 9-substituted 2-(2-n-alkoxyphenyl)-purin-6-ones
12/25/1996CN1138575A 4-aminobenzoylguanidine derivatives
12/25/1996CN1138499A Catalysts for amination of alcohols, ketones and aldehydes
12/24/1996US5587479 Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists
12/19/1996WO1996040737A1 Reversible cysteine protease inhibitors
12/19/1996WO1996040673A1 Novel urea- and thiourea-type compounds
12/19/1996WO1996040672A1 Combinatorial libraries having aminodiol monomer subunits
12/19/1996WO1996040665A1 N-substituted piperazine nonoates
12/19/1996WO1996040664A2 Preparation of immunogens and other conjugates of drugs
12/19/1996WO1996040663A1 Di- and tri-aminoguanidines and their use to inhibit the advanced glycosylation of proteins
12/19/1996WO1996040661A1 N-alkyl ammonium acetonitrile bleach activators
12/19/1996WO1996040660A1 Certain substituted benzylamine derivatives: a new class of neuropeptide y1 specific ligands
12/19/1996WO1996040647A1 α-(1,3-DICARBONYLENOL ETHER) METHYL KETONES AS CYSTEINE PROTEASE INHIBITORS
12/19/1996WO1996040641A1 Sulfonamide derivatives as cell adhesion modulators
12/19/1996WO1996040136A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONIST
12/19/1996WO1996040098A2 Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
12/19/1996WO1996040097A1 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders
12/19/1996CA2223978A1 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders
12/19/1996CA2223426A1 N-substituted piperazine nonoates
12/19/1996CA2223268A1 .alpha.-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors
12/19/1996CA2222972A1 Reversible cysteine protease inhibitors
12/19/1996CA2221744A1 Alpha 1a adrenergic receptor antagonists
12/19/1996CA2220958A1 Certain substituted benzylamine derivatives: a new class of neuropeptide y1 specific ligands
12/19/1996CA2196902A1 N-alkyl ammonium acetonitrile bleach activators
12/18/1996EP0748310A1 Diesters of carbonic acid endowed with antiviral and anti-inflammatory activity
12/18/1996CN1138322A 2,3-diaminopropionic acid derivative
12/17/1996US5585519 Microbicides
12/17/1996US5585513 Fungicides
12/17/1996US5585492 LTA4 Hydrolase inhibitors
12/17/1996US5585397 Viricides
12/17/1996US5585389 Amidrazones and their use as insecticidal and acaricidal agents
12/17/1996CA2050492C Piperazine compounds, processes for preparation thereof and medical uses thereof
12/17/1996CA2032513C Substituted isoxazolidines and isoxazolines as intermediates for delmopinol and preparation of delmopinol using these intermediates
12/17/1996CA1338796C Color photographs, a process for preparing them and color photographic materials employed therefor
12/12/1996WO1996039386A1 Piperidine derivatives as neurokinin antagonists
12/12/1996WO1996039384A1 Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors
12/12/1996WO1996039380A1 BIS-ARYLSULFONYLAMINOBENZAMIDE DERIVATIVES AND THE USE THEREOF AS FACTOR Xa INHIBITORS
12/12/1996WO1996039142A1 Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride
12/11/1996EP0625140B1 Cyclopropyl n-hydroxyurea and n-hydroxyacetamides which inhibit lipoxygenase
12/11/1996CN1137525A Naphthyl compounds, intermediates, compositions, and methods
12/10/1996US5583249 Pesticides
12/10/1996US5583247 7-substituted quinone methides as inhibitors for unsaturated monomers
12/10/1996US5583238 Method for making intermediates useful in synthesis of retroviral protease inhibitors
12/10/1996US5583233 Retroviral protease inhibiting compounds
12/10/1996US5583232 Treating human immunodeficiency virus infections
12/10/1996CA2032224C 3-(n-methyl-n-alkyl)-amino 2-methoxymethylene propan 1-ol derivatives, a preparation process of the same and therapeutical compositions containing them
12/05/1996WO1996038439A1 Novel polymorphs of lesopitron dichlorohydrate and its hydrated forms, preparation methods and compositions containing them
12/05/1996WO1996038414A1 Benzoyl piperidines/pyrrolidines for enhancing synaptic response
12/05/1996DE19519508A1 Radio-halogenated benzamide derivs., useful in diagnosis and treatment of tumours
12/05/1996CA2196425A1 Novel polymorphs of lesopitron dichlorohydrate and its hydrated forms, preparation methods and compositions containing them
12/04/1996EP0745898A1 Process for making a developed chromogenic color photographic image by using a compound which is able to react with aromatic primary amines
12/04/1996EP0745597A2 Novel melatonergic indanyl piperazines or homopiperazines
12/04/1996EP0745587A1 Process for the preparation of amine oxides
12/04/1996EP0691965B1 Photochromic naphthopyran compounds
12/04/1996CN1137267A N,N'-bis (2-hydroxybenzyl) ethylenediamine-N,N'-diacetic acid derivatives as chelating agents
12/04/1996CN1137035A Basic group substituted benzoyl guanidine, its preparing process, its use as medicine or diagnostic reagent, and medicine containing the same
12/03/1996US5580984 Retroviral protease inhibiting compounds
12/03/1996US5580904 Penetrate blood-brain barrier
12/03/1996CA2175395A1 Melatonergic indanyl piperazines or homopiperazines
11/1996
11/28/1996WO1996037484A1 Process for producing 5,6-dihydro-1,3-oxazines
11/28/1996DE19518681A1 Verfahren zur Herstellung von 5,6-Dihydro-1,3-oxazinen Process for the preparation of 5,6-dihydro-1,3-oxazines
11/27/1996EP0744392A1 A new one-pot process for the preparation of 7-aryl-2,6-disubstituted quinone methides
11/27/1996CN1136562A Estrogen excitant/antagonist
11/27/1996CN1136556A Aromatic group substituted W-amino alkyl amide and alkyl amide
11/27/1996CN1136548A Process for preparation of cyclopentadinyl compounds and compounds obtained therefrom
11/27/1996CA2177327A1 One-pot process for the preparation of 7-aryl-2,6-disubstituted quinone methides
11/26/1996US5578594 Anticoagulants
11/26/1996US5578542 For the preparation of a polymer having reduced hysteresis characteristics
11/26/1996US5578251 Method of preparing polar disulfone-functionalized molecules
11/21/1996WO1996036621A1 Method for recovering or recirculating stable nitroxide radicals
11/21/1996WO1996036620A1 Diaryldiamine derivatives and their use as delta opioid (ant)-agonists
11/21/1996CA2221380A1 Diaryldiamine derivatives and their use as delta opioid (ant)-agonists
11/20/1996CN1136039A |3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy¨-pyridine, pyrimidine and benzene derivatives as alpha1-adrenoceptor antagonists
11/19/1996US5576335 Urea derivatives and their use as ACAT inhibitors
11/19/1996US5576334 Acylurea derivatives
11/19/1996US5576332 Treatment of vision defects and cardiovascular disorders with aminealkyloxy ester derivatives
11/19/1996US5576274 Hydrocarbon polymer reacted with catechol or hydroquinone then aminated, antisludging agents